Toxin-antitoxin (TA) systems are widespread genetic modules in the genomes of bacteria and archaea emerging as key players that modulate bacterial physiology. They consist of two parts, a toxic component that blocks an essential cellular process and an antitoxin that inhibits this toxic activity during normal growth. According to the nature of the antitoxin and the mode of inhibition, TA systems are subdivided into different types. Here, we describe the characterization of a type II-like TA system in Escherichia coli called EzeT. While in conventional type II systems the antitoxin is expressed in trans to form an inactive proteinprotein complex, EzeT consists of two domains combining toxin and cis-acting antitoxin functionalities in a single polypeptide chain. We show that the C-terminal domain of EzeT is homologous to zeta toxins and is toxic in vivo. The lytic phenotype could be attributed to UDP-N-acetylglucosamine phosphorylation, so far only described for type II epsilon/zeta systems from Gram-positive streptococci. Presence of the N-terminal domain inhibits toxicity in vivo and strongly attenuates kinase activity. Autoinhibition by a cis-acting antitoxin as described here for EzeT-type TA systems can explain the occurrence of single or unusually large toxins, further expanding our understanding of the TA system network.
Introduction
Toxin-antitoxin (TA) modules have been identified in almost all bacterial genomes (Leplae et al., 2011) , where they act to induce cell death or dormancy . Thereby, TA systems contribute to the stabilization of mobile genetic elements, either in plasmid maintenance by provoking post-segregational killing (Gerdes et al., 1986; Zielenkiewicz and Ceglowski, 2001) or in the establishment and preservation of transposable elements in the chromosome (Szekeres et al., 2007; Wozniak and Waldor, 2009) . Furthermore, these systems function as stress response elements by inducing dormancy (Gerdes et al., 2005; Christensen-Dalsgaard et al., 2010) and have been implicated in the regulation of persister cell formation (Correia et al., 2006; Gerdes and Maisonneuve, 2012) , biofilm formation (Wang and Wood, 2011; Kasari et al., 2010) or virulence (Harvey et al., 2011; De la Cruz et al., 2013) .
Growth regulation by TA modules is exerted by a toxic protein, which interferes with an important cellular process such as replication, translation or cell wall biosynthesis (Goeders and Van Melderen, 2014) . Tight control of this toxic activity is required to prevent self-intoxication under favorable growth conditions . Neutralization is mediated by an antitoxin, generally by preventing the translation of the toxin (Fozo, 2012; Wang et al., 2012) or inhibition of toxicity by complex formation with the toxic protein (Blower et al., 2012; Gerdes, 2013) . Dependent on the nature of the antitoxin, either protein or RNA, and the mode of inhibition, TA systems are classified into different types (Aakre et al., 2013; Schuster and Bertram, 2013) . Among these different TA types, type II TA modules have been studied most extensively. They typically consist of two adjacent protein-coding genes organized in a bicistronic operon Gerdes and Maisonneuve, 2012) . The upstream gene encodes the small, proteolytically instable antitoxin, which forms an inactive protein-protein complex with the downstream gene product, the toxin. Degradation of the antitoxin by cellular proteases releases the toxin, which eventually leads to cell death or stasis. Commonly, the antitoxin contains an additional DNA-binding domain and binds to the promoter of the bicistron to repress transcription (Gerdes and Maisonneuve, 2012) . This autoregulation can be further enhanced by TA complex formation in a process called conditional cooperativity (Garcia-Pino et al., 2010) .
Type II toxins of the zeta family are associated with small, proteinaceous epsilon antitoxins. Studies on two streptococcal systems, the ε/ζspy plasmid maintenance system from Streptococcus pyogenes (Camacho et al., 2002; Zielenkiewicz and Ceglowski, 2005) and the chromosomal system PezAT from Streptococcus pneumoniae (Khoo et al., 2007) , show that in the inactive heterotetrameric complex, two zeta molecules bind to a central epsilon dimer (Meinhart et al., 2003; Khoo et al., 2007) . Inhibition is accomplished by sterically blocking substrate binding, which is performed by several residues of the N-terminal α-helix of epsilon protruding into the adenosine triphosphate (ATP)-binding site of zeta. Epsilon/zeta TA systems were originally discovered as plasmid maintenance systems in Gram-positive streptococci (Ceglowski et al., 1993) , but were found to be widespread in prokaryotic genomes (Leplae et al., 2011) . Recently, zeta toxins were identified as highly abundant modules in pathogenic organisms and were shown to specifically interfere with peptidoglycan synthesis by converting the murein precursor UDP-N-acetylglu cosamine (UNAG) into UDP-N-acetylglucosamine-3' phosphate (UNAG-3P) . Formation of UNAG-3P decreases available UNAG levels in the cell and inhibits enzymes of the peptidoglycan synthesis pathway. Additionally, phosphorylation was speculated to interfere with the synthesis of other UNAG-comprising glycoconjugates such as teichoic acids and lipopolysaccharides . As a result, zeta toxin activity reduces the stability of the cell wall, which leads to cell lysis upon overexpression . In contrast, expression of lower levels of zeta or short-living mutants showed a delayed membrane permeabilization preceded by a reduction in ATP and macromolecule synthesis and the induction of dormancy (Lioy et al., 2012; Tabone et al., 2014) . It thus seems that the reported bacteriocidal or bacteriostatic effect of zeta toxicity strongly depends on the cytosolic concentrations of free toxin and other experimental conditions.
The wide distribution of zeta toxins and their potential role in pathogenicity prompted us to further investigate homologous proteins outside the phylum firmicutes. We describe here the characterization of a novel zeta homologue from the Gram-negative bacterium Escherichia coli. This protein, designated EzeT for E. coli epsilon/zeta, is a UNAG kinase inhibited by its own N-terminal cis-acting antitoxin domain and therefore the first described autoinhibited TA system.
Results

N-terminally elongated zeta toxins in Gram-negative bacteria
We searched the publicly available genome-databases for epsilon/zeta TA operons in Gram-negative bacteria and identified conserved operons in 364 different E. coli strains of the phylogroup B1 that exclusively encode a zeta homologue, but lack any adjacent open-reading frame (ORF) of a potential epsilon antitoxin. These remarkable zeta-like genes are located in a conserved 3.4 kb islet that is inserted between lysC encoding for the lysine-sensitive aspartokinase III and yjbD, a gene of unknown function. In addition to the zeta toxin locus, this islet contains two additional hypothetical ORFs, which are encoded from the complementary strand (Fig. 1A) .
Sequence comparisons revealed that this zeta homologue is highly conserved. On the amino acid (aa) level, 37 homologous groups were identified that are similar in length (304-310 aa) and share an overall aa sequence identity of 88% (Supplementary Figure S1) . Although predominantly found in the genome of E. coli, we identified similar solitary zeta homologues in the genome of other γ-proteobacteria such as the closely related Escherichia fergusonii, but also in Actinobacillus minor and Succinatimonas sp. Using the NCBI BLAST tool (Altschul et al., 1990; 1997) , the C-terminal part of the gene product was identified to contain a zeta toxin domain with 38% and 47% aa similarity to the streptococcal zeta toxins ζ spy and PezT, respectively (Fig. 1B) . Within these zeta domains, all residues that have previously been shown to be essential for ATP-binding and hydrolysis as well as UNAG binding (Meinhart et al., 2003; Khoo et al., 2007) are conserved, suggesting that these zeta proteins are active UNAG kinases. Most importantly, these zeta toxins contain a polypeptide stretch of approximately 80 aa at their N-terminus that was predicted to form three helices (Fig. 1B) . These secondary structure elements are reminiscent to those of ε spy and PezA epsilon antitoxins that fold into three-helix bundles (Meinhart et al., 2003; Khoo et al., 2007) . Therefore, we termed this gene ezeT for E. coli epsilon/zeta. Notably, we also found genes encoding for closely related zeta toxins lacking this N-terminal polypeptide stretch in other host-associated Gram-negative bacteria [between 39% and 43% aa sequence identity to the zeta domain of EzeT (Supplementary Figure S2) , but only 27% to 34% to ζspy and PezT]. Moreover, the conservation of the catalytic residues strongly suggests that these proteins are active UNAG kinases. They are encoded together with a separate ORF of a putative antitoxin in a conventional bicistronic TA operon. Most importantly, secondary structure predictions suggest that these separate antitoxins fold into three helices and all of them, including the N-terminal domain of EzeT, are highly conserved at their N-terminus (Supplementary Figure S3) . In conclusion, these results suggest that the N-terminal, three-helix region of the EzeT polypeptide chain folds into an individual epsilon antitoxin-like domain that is fused to the zeta toxin domain.
EzeT is a functional gene
To demonstrate that the ezeT locus constitutes a functional gene and to exclude that EzeT is a pseudogene we integrated the coding sequence for a C-terminally hemagglutinin (HA)-tagged version of EzeT into the genomic ezeT locus of E. coli W. Indeed, we could isolate EzeT from this strain by immunoprecipitation and thereby demonstrate that the protein is expressed in vivo ( Fig. 2A) . However, EzeT protein levels seem to be low during growth at 37°C and standard growth conditions, as the protein can barely be detected by immunoblotting without enrichment by immunoprecipitation (data not shown).
To further investigate transcriptional regulation, we closer examined the putative promoter region upstream of ezeT. Therefore, we created transcriptional fusions of the 250 nucleotide region upstream to the ezeT ORF and the coding sequence of superfolder GFP (Pedelacq et al., 2006) in a reporter plasmid, similar to experiments measuring TA transcription activity in S. pneumoniae (Chan et al., 2014) . Indeed, we detected moderate GFP fluorescence in E. coli DH5α cells that were transformed with this reporter plasmid (Fig. 2B) , showing that expression is not dependent on transcription of the upstream lysC gene. Furthermore, upon mutation within the putative ShineDalgarno motif (Supplementary Table S1 ), GFP fluorescence decreased to undetectable levels, demonstrating that this sequence is a ribosomal binding site. As many TA systems are autorepressed by the TA product (Garcia-Pino et al., 2010; Gerdes, 2013) , we wondered whether EzeT does interfere with GFP expression from the reporter plasmid. However, even when we expressed EzeT at high concentrations, GFP fluorescence remained unchanged and was similar to the signal obtained for cells that did not contain any EzeT encoding plasmid (Fig. 2B ). Yet, a palindromic sequence located approximately 120 nucleotides upstream from the ezeT start codon (Supplementary Table S1 ) might be important for transcriptional regulation by an unknown factor. Although plausible, this was rather unlikely as we could not associate it with a consensus sequence for known bacterial regulators (Browning et al., 2010) , nor could we identify related palindromic sequences in the genome of E. coli strains in a BLAST search. In fact, we could delete this region from the reporter plasmid and did not detect any change in GFP fluorescence (Fig. 2B) . Furthermore, we could also show that this observation was not strain specific, as we did not observe any difference when these experiments were performed with E. coli W cells that carry the ezeT locus (data not shown). Within the residual 70 nucleotides containing the promoter region we could identify a conserved −10 element, but no common −35 motif associated with binding of the housekeeping sigma factor σ 70 (Fig. 2B ). This could either indicate that the promoter is A. Genome annotation of the EzeT encoding 3.4 kb islet (black) and its flanking regions (gray). In addition to ezeT, hyp1 and hyp2 are located on the complementary strand and encode a putative nucleotidyl transferase and a putative SPFH domain/band 7 protein homologue, respectively. B. Amino acid sequence alignment of EzeT from Escherichia coli W (ADT77674) with ζspy from Streptococcus pyogenes (YP_232762) and PezT from Streptococcus pneumoniae (NP_345525). Residues are colored according to similarity (identity: dark green, low homology: yellow). The secondary structure prediction for EzeT is shown above the sequence. Red arrows indicate predicted β-strands, yellow tons predicted α-helices of the zeta toxin domain. Blue tons indicate predicted α-helices in the N-terminal EzeT domain. The Walker A and B motifs are highlighted in red, residues in the UNAG binding loop in gray and residues that were mutated by site-directed mutagenesis are marked with a diamond (◆).
suboptimal for σ 70 binding or that transcription is initiated by binding of the alternative sigma factor σ
38
. When we mutated within the −10 hexamer of the reporter plasmid, GFP expression was abolished, showing that this region is a functional sigma factor binding site. Noteworthy, when we mutated the region downstream to the −10 element, we observed increased GFP expression for unknown reasons. Furthermore, we could optimize σ 70 binding by mutation to a conventional −35 site and observed dramatically increased GFP expression. In conclusion, under the conditions tested, ezeT seems to be weakly transcribed from a promoter that contains a conventional −10 element.
EzeT phosphorylates UNAG in vitro
The conservation of residues important for UNAG kinase activity and the presence of the N-terminal epsilon antitoxin-like domain strongly suggest that EzeT is an active, but autoinhibited UNAG kinase. Thus, we wondered whether we could detect any residual kinase activity for full-length EzeT or if the enzyme is fully inhibited.
Similarly, in vitro assays have shown that ζ spy still exhibits residual UNAG kinase activity in presence of equimolar amounts of the εspy antitoxin . Therefore, we cloned the ezeT ORF into an inducible expression vector and recombinantly expressed EzeT in an E. coli laboratory strain that does not encode a known endogenous UNAG kinase. EzeT was purified to homogeneity, and similar to HA-tagged EzeT, a single-protein species that migrated with an apparent electrophoretic mobility of 35 kDa in an SDS-PAGE was observed (data not shown). Indeed, when we incubated EzeT with UNAG, ATP and MgCl2 at 25°C for 24 h, significant amounts of UNAG-3P and ADP were detected after assay separation by anion exchange chromatography (Fig. 3A) . Spectroscopic quantifications showed that 60% of UNAG had been phosphorylated and an equimolar amount of ADP was formed. However, separation of the reaction products after 3 h of incubation with EzeT revealed that only 9% of UNAG was phosphorylated after 3 h of incubation. Thus, either EzeT has low phosphotransferase activity or indeed is inhibited by its N-terminal region. Ultimately, we can exclude that the Supplementary Table S1. observed enzymatic activity is due to contamination, as mutation of the catalytically essential Walker A lysine K121 to an alanine residue (EzeT_K121A) fully abolished UNAG kinase activity.
EzeT toxicity in E. coli is caused by UNAG-3P production
To corroborate our hypothesis that EzeT is an autoinhibited zeta toxin, we investigated the growth phenotype in E. coli laboratory strains induced by expression of fulllength and truncated active (EzeTΔN83) and inactive (EzeTΔN83_K121A) EzeT variants that only contained the UNAG kinase domain from the respective plasmids (see Supplementary Materials and Methods). To this end, we continuously monitored cell propagation in liquid cultures grown at 20°C by measuring the optical density at 600 nm (OD 600) after induction with isopropyl-β-Dthiogalactopyranosid (IPTG) (Fig. 4A ). In parallel, the envelope status of cells upon protein expression was investigated by fluorescently monitoring the propidium iodide influx into damaged E. coli cells (Fig. 4B ) and the determination of the number of colony-forming units (CFUs) (Fig. 4C ) at various time points. E. coli cells that expressed full-length EzeT grew normally (Fig. 4) , suggesting that full-length EzeT is not significantly toxic. In contrast, cells that expressed EzeTΔN83 showed a strong reduction in viability after toxin induction and the decrease in OD 600 ( Fig. 4A ) was paralleled by a strong increase in propidium iodide influx ( Fig. 4B ) indicative of cell permeabilization. Similarly, the number of CFUs decreased strongly and dropped by 2000-fold after 1 h of induction. However, the apparent onset of observingimpaired fitness was earlier in experiments where the number of CFUs was determined than when monitoring OD600 and propidium iodide influx. Furthermore, at late time points (180 min post induction; Fig. 4A ), the OD600 did not decrease as dramatically as the number of CFUs at these time points would suggest.
Therefore, we performed phase contrast and live/dead staining microcopy experiments at the single cell level at different time points post induction (Fig. 5) . Indeed, cultures expressing EzeTΔN83 revealed a number of dead cells, which significantly increased over the time course of toxin induction (Fig. 5A) . Furthermore, the number of empty ghost cells increased in parallel. Note, that during the experiments, the volume of cell culture for harvesting had to be increased to ensure a representative ensemble of live and dead cells in the field of view of the microscope at the given magnification. Strikingly, after 90 min and even more pronounced at later time points, surviving bacteria lost their rod-shaped morphology and rounded cells reminiscent of spheroplasts appeared (Fig. 5A) . We therefore concluded that cell wall synthesis was strongly impaired in the presence of EzeTΔN83. The observed morphological changes and the lytic phenotype were most likely the result of an impaired peptidoglycan synthesis similar to what has been described for other zeta toxins . This might also explain why, on the one hand, the OD 600 did not decrease as we expected, as empty ghost cells and cellular debris contributed to light scattering. On the other hand, the corrupted peptidoglycan layer of damaged cells might reduce the plating efficiency, an A. UNAG phosphorylation by EzeT after 3 h (dashed green line, 9% turnover) and 24 h (green line, 60% turnover). As opposed to the negative control (EzeT_K121A after 24 h, pink line) the reaction products ADP and UNAG-3P are formed. Peak integration of the product peaks indicates that both compounds are formed in equimolar amounts. The asterisk (*) denotes the retention time of AMP, which probably is the product of a minor adenylate kinase contamination. Black: Separation of an authentic standard containing UNAG and ATP. B. High-performance liquid chromatography analysis of low-molecular-weight-metabolite extracts from cells expressing wild-type and mutated EzeT variants from pET28b(EzeT) (green), pET28b(EzeTΔN83) (red), and pET28b(EzeTΔN83_K121A) (blue) constructs. Strong accumulation of UNAG-3P is seen only with EzeTΔN83. Separation of an authentic standard containing UNAG and UNAG-3P is shown in black.
effect that has been also observed for Proteus mirabilis spheroplasts (Martin, 1983) . Furthermore, we cannot exclude that the remaining EzeTΔN83 levels in the cytosol of surviving cells led to cell death after plating and overnight incubation. In contrast, mutation of the Walker A lysine in EzeTΔN83_K121A abolished the lytic phenotype (Figs 4 and 5B), which is in perfect agreement with the lack of UNAG kinase activity that we observed for similarly mutated EzeT_K121A in vitro.
To prove that the lytic phenotype is caused by accumulation of UNAG-3P in vivo, we prepared low-molecularweight-metabolite extracts from cells that expressed EzeTΔN83 for 2 h and separated them by highperformance liquid chromatography (Fig. 3B) . High levels of UNAG-3P were detected in extracts from cells that expressed EzeTΔN83, but not in those expressing enzymatically inactive EzeTΔN83_K121A (Fig. 3B ). This supports strongly that EzeT is a zeta toxin that interferes with peptidoglycan synthesis by producing the MurA inhibitor UNAG-3P similar as described for other zeta toxins Lioy et al., 2012) . Furthermore, no UNAG-3P could be detected in extracts from cells that expressed full-length EzeT (Fig. 3B) , showing that removal of the N-terminal domain leads to activation of the toxin and accumulation of a toxic compound in vivo.
A cis-acting antitoxin is located at the N-terminus
In conventional type II TA systems the antitoxin forms a protein-protein complex with the toxin, thereby inhibiting toxicity. While overexpression of the toxin leads to cell death or stasis, co-expression of the antitoxin rescues cell growth . We therefore wondered, whether we can convert EzeT into a type II TA system and expressed the toxin domain (EzeTΔN83) and the N-terminal domain [EzeT(1-82)] separately from arabinose and IPTG-inducible promoters, respectively. Indeed, when we co-induced expression of EzeT(1-82) and EzeTΔN83 we observed similar growth profiles as for full-length EzeT, demonstrating that we can rescue cell viability by trans-complementation (Fig. 6A) . In case of exclusive EzeTΔN83 expression, we observed a decrease in OD 600 (Fig. 6A) , similar as we found when expressing EzeTΔN83 from an IPTG-inducible T7 promoter (Fig. 4A) . However, the onset of decreasing OD600 was delayed in this experiment when compared with T7 expression (4 h instead of 90 min), which is probably due to low-level EzeT(1-82) expression caused by leakiness of the IPTG-inducible promoter and weaker toxin expression because of the use of an arabinose inducible system. Strikingly, within the delay time of increasing OD600 we could still rescue growth by induction of EzeT(1-82) expression (Fig. 6A) . In contrast, this Growth curves (A), propidium iodide influx (B) and CFUs (C) of Escherichia coli BL21(DE3)-RIL cells expressing wild-type and mutated EzeT variants from pET28b(EzeT) (green), pET28b(EzeTΔN83) (red), and pET28b(EzeTΔN83_K121A) (blue) constructs (mean values ± SD, n = 3). Expression from an empty pET28b vector was used as control (gray).
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Propidium iodide rescue was not possible anymore after 4 h, when the OD600 started to decrease. Such a failure in restoring normal growth by antitoxin expression at later stages of toxin poisoning is generally known as the 'point-of-no-return' (Amitai et al., 2004) , which has also been described for the homologous two-particle system ε/ζspy (Lioy et al., 2006; 2012) . To more closely investigate the mechanism of inhibition, we consecutively re-added the N-terminal helices to EzeTΔN83 and monitored cell growth, morphology and viability in cultures grown at 20°C (Fig. 6B-D) . Only when we provided all three helices, normal growth of E. coli cells expressing EzeT was restored. Expression of constructs with truncations of the first (EzeTΔN36, Fig. 6C and D) or first and second (EzeTΔN62, Supplementary Figure S4 ) helix led to a decrease in OD 600 and CFUs and caused a rounded morphology indicative of cell wall defects ( . Note, that in case of expression of truncation constructs as well as mutated EzeT variants a significant drop in CFUs was observed after 3 h, although the OD600 decreased only for expression of the truncated proteins (mean values ± SD, n = 3) and that the expression levels were comparable for all constructs (see Supplementary Figure S6 ).
demonstrating that mainly the first N-terminal helix of EzeT contributes to the inhibition of the toxic activity. However, the toxic effects of the EzeTΔN62 variant were less pronounced than expected, which is most likely caused by a severely impaired stability of this construct (Supplemental Figure S6) . Despite the significantly reduced protein levels of the EzeTΔN62 variant, we still could observe the lytic phenotype (Supplemental Figure S4) , which demonstrates the potency of toxicity of the UNAG kinase activity in E. coli. In addition, the increase in propidium iodide fluorescence observed for bulk measurements of cultures expressing the two truncation constructs show that membrane permeabilization occurs in parallel with the decrease in OD 600 (Supplemental Figure S7 ), further supporting the lytic phenotype. We propose that, similar to other epsilon/zeta systems, inhibition is mainly performed by the first N-terminal helix of the antitoxin domain; a hypothesis, which is also supported by the high sequence conservation in the N-terminal stretch of EzeT and related bicistronic systems (Supplemental Figure S3 ). Indeed, when we mutated these conserved residues, which according to secondary structure prediction will locate on one side of a helix (namely Met5, Asp8, Asn12 and Gln16) to alanine residues, we observed a decrease in CFUs similar as observed for the truncation constructs (Fig. 6D) , and cells expressing this variant showed rounded morphology indicative of a deficiency in peptidoglycan synthesis (Fig. 6B and Supplemental Figure S8 ). This observation is in agreement with the mechanism of inhibition by other epsilon antitoxins, where the first amino acids of epsilon protrude into the ATPbinding site, thereby inhibiting substrate binding (Meinhart et al., 2003; Khoo et al., 2007) . However, cell lysis monitored by live/dead stains is much less pronounced in case of expression of the EzeT_M5A_D8A_N12A_Q16A variant (Supplementary Figure S8) than it is when the EzeTΔN36 variant was expressed (Supplementary Figure S5) . It thus seems that the residues altered to alanine side chains contribute to inhibition to some extent. However, binding of the N-terminal helix, even when mutated, can still block access of ATP to the nucleotide binding site to a significant extent.
EzeT toxicity is temperature dependent
When we investigated the lytic phenotype of the EzeTΔN83 variant at different temperatures, we found that it was more pronounced at low temperature. In fact, a decrease in OD 600 was only detectable at temperatures below 30°C (Fig. 7A ) and the number of CFUs dramatically decreased (> 5000-fold) at these temperatures (Fig. 7B) . In contrast, neither a decrease in OD600 nor in the number of CFUs was observed when the inactive EzeTΔN83_K121A control was expressed at these temperatures ( Fig. 7C and D) . However, when EzeTΔN83 was expressed at 30°C the OD 600 constantly increased, whereas the number of CFUs was reduced similar as observed at lower temperatures, indicating that cell wall damage occurs to some extent. In contrast, neither cell death nor a change in morphology were observed in phase contrast or live/dead stains of these cultures (data not shown), suggesting that toxicity is relatively weak. We therefore believe that exposure to the toxin upon longer time scales on agar plates still results in an apparent reduction of survivors, which is the case when determining the number of CFUs. Strikingly, neither the OD 600 nor the number of CFUs decreased, when EzeTΔN83 was expressed at 37°C, indicating that EzeT is not functional at higher temperature. This observation is in perfect agreement with our in vitro studies that revealed a melting temperature of 38°C for full-length EzeT (Supplemental Figure S9 ). These results show that EzeT is most toxic at ambient temperature and might function as a thermosensor to regulate bacterial survival outside the host.
Discussion
In this study, we identified and characterized the ezeT locus, an E. coli gene, which is homologous to type II epsilon/zeta TA systems. However, EzeT features a hitherto undescribed mode of toxin inactivation that differs from protein-protein complex formation of type II TA systems (Gerdes et al., 2005; . Instead, EzeT consists of two domains featuring toxin and cis-acting antitoxin functionalities within a single polypeptide chain and the interaction between these two domains leads to autoinhibition of the toxic activity. Thus, EzeT is the founding member of a new type of proteinaceous TA systems. The toxic activity of EzeT is established by its C-terminal domain that contains all catalytic motifs of UNAG kinases . We found that this domain induces a lytic phenotype similar as described for zeta toxins (Lioy et al., 2006; and induce cell wall defects that cause a rounded morphology of surviving cells. However, the toxicity is abrogated by the presence of the N-terminal 82 aa domain of EzeT. Notably, inhibition does not require covalent linkage of the N-and C-terminal domain as we can rescue cells that express the toxic domain by expression of the N-terminal domain in trans. The inhibitor function is mainly established by the very N-terminal part of the polypeptide chain as mutations of residues located in the first four turns of the N-terminal helix did interfere with toxin domain inhibition and removal of the first predicted helix fully abolished inhibition. Thus, the mechanism of inhibition by the N-terminal domain might be similar to inhibition by epsilon antitoxins (Meinhart et al., 2003; Khoo et al., 2007) . In addition, we show that EzeT is capable of phosphorylating UNAG in vitro and is thus an authentic zetalike UNAG kinase encoded in the genome of Gramnegative bacteria. However, the apparent phosphorylation efficiency of autoinhibited EzeT was weak, indicating that the N-terminal domain blocks substrate binding and only occasional complex opening allows substrate binding and turnover. Accordingly, we could not detect the enzymatic product UNAG-3P in vivo when full-length protein was expressed suggesting that under physiological substrate concentrations, EzeT is efficiently autoinhibited. In contrast, UNAG-3P was highly enriched in cells that exclusively expressed the C-terminal toxin domain.
The described mechanism of autoinhibition in EzeT TA systems reminds of bacterial zymogenic pro-enzymes (Demidyuk et al., 2010) , which contain additional propeptides that prevent cytosolic toxicity. While many propeptides are required for proper folding of the enzymatic domain (Demidyuk et al., 2010) , the catalytic domain of EzeT is enzymatically active, even without the cis-acting antitoxin domain. In addition, the pro-peptide of classical bacterial zymogens such as gingipain (de Diego et al., 2013) , elastase (Kessler and Safrin, 1994) or α-lytic protease (Baker et al., 1992) prevents detrimental selfintoxication in the cytosol by the enzymatic domain, which only becomes activated by intra-or intermolecular prote- Escherichia coli BL21(DE3)-RIL cells were transformed with pET28b(EzeTΔN83) (A, B) and pET28b(EzeTΔN83_K121A) (C, D) plasmids and proteins were overexpressed at different temperatures (dark blue: 16°C, blue: 20°C, purple: 25°C, red: 30°C, dark red: 37°C) and OD600 (A, C) and CFUs (B, D) of the cultures were determined (mean ± SD, n = 3). For EzeTΔN83_K121A the OD600 increases steadily (C) albeit with temperature-dependent doubling times. In contrast, EzeTΔN83-expression leads to a massive decrease in OD600 after 90 min (A) for temperatures below 30°C. Similarly, a significant drop in CFUs (B) is detectable for this temperature ranges below, but also at 30°C. In contrast, at 37°C the OD600 and the number in CFUs were comparable in both experiments. Note, that at 37°C EzeT ΔN83_K121A as well as EzeTΔN83 are unstable and inclusion bodies are formed. Most likely this causes an overexpression artifact leading to a decrease in the observed number of CFUs at later time points even in the inactive mutant. The total amount of EzeTΔN83 and EzeTΔN83_K121A was comparable at each temperature (see Supplementary Figure S10 ). olysis post-secretionally (Demidyuk et al., 2010) . Although it is very likely that, similar to bacterial zymogens, EzeT becomes activated by proteolytic removal of the N-terminal domain, it will remain in the cytosol as we neither could detect any signal sequence for secretion in EzeT nor observe any proteolytic truncation of such a potential signal peptide. Thus, EzeT will induce programmed cell death when autoinhibition is not maintained permanently in the host, similar to what has been described for all other TA systems . Related but artificial zymogenic TA systems have been designed recently by fusion of the antitoxin MazE with the toxin MazF that can be cleaved and activated by site-specific proteases (Park et al., 2012; Shapira et al., 2012) . Although a zymogenic activation of EzeT is conceivable, it is also plausible that partial unfolding of the N-terminal domain or structural rearrangements that open the domain interface by chaperones or other protein factors lead to toxin activation.
A tight regulation of toxic activities of TA systems in the cytoplasm is most likely required to restrict cell death or stasis to specific circumstances in order to be beneficial for survival of a bacterial population. Binding affinities determined for streptococcal epsilon/zeta systems suggest that regulation of toxin activation is purpose-or host-specific. Whereas the antitoxin and the toxin bind with micromolar affinity to each other in the plasmid encoded ε/ζ spy system (Camacho et al., 2002) , the homologous chromosomally encoded PezA/PezT complex has femtomolar affinity (Mutschler, 2010) . It is conceivable, that EzeT establishes two layers of potential regulation by affinity. The first layer is accomplished by the covalent tethering of the antitoxin domain to the toxin within the polypeptide chain. Such tethering entropically favors inhibition and the affinity is most likely moderate to high. As the antitoxin domain can still inhibit the toxin domain when provided in trans, the second layer of regulation could be established after proteolysis within the tether. Nevertheless, the affinity of such a proteolytically separated EzeT system would be much weaker. Moreover, a full rescue after toxin activation would only be possible by toxin degradation, as the cisacting antitoxin cannot be replenished. This would set EzeT apart from most other TA systems, where re-expression of the antitoxin from the bicistronic operon can fully rescue within a certain amount of time (Amitai et al., 2004) .
Although the activation of EzeT is most likely different than it is for classical type II TA systems, the ancestor of EzeT might be a bicistronic operon of the latter type. Notably, related bicistronic operons are found in several other Gram-negative bacteria. These operons encode for zeta toxins that are highly homologues to the toxic domain of EzeT. Most importantly, also the N-terminal region of EzeT and those of the antitoxin proteins are highly homologous (Supplementary Figure S3) . Thus, it is conceivable that EzeT originates from mutations that lead to translational fusions within these bicistronic operons. It is worthwhile to mention, that there is the remaining possibility that this fusion would have led to a permanently inactive TA gene and EzeT does not become activated at all. However, we did not find a single copy of ezeT in any annotated E. coli strain in which either the coding region of the toxin domain was destroyed by frame shift mutations or the toxin became inactivated by mutation of catalytically important residues. Such mutated TA operons, in which the reading frame of the toxin would be destroyed, would have a metabolic advantage over EzeT, as we observe residual UNAG kinase activity for the full-length protein. The latter observation would thus establish a selective pressure for mutated EzeT variants, unless a functional EzeT system is more beneficial for E. coli. Moreover, the genomic neighborhood of the ezeT locus in the 3.4 kb islet and the bicistronic operons are unrelated. This indicates that the autoinhibited TA gene has been transferred by horizontal gene transfer and is now stably integrated in the E. coli chromosome. Maintenance of these mobile elements is more likely for a functional EzeT than for a non-functional EzeT TA system as the latter lacks any selective pressure.
Furthermore, we show that ezeT transcription is not autoregulated by conditional cooperativity, a mechanism that is commonly used by most type II TA systems (Garcia-Pino et al., 2010; Gerdes, 2013) . Instead, its regulation might be similar to the MazEF TA system of Staphylococcus aureus, which is transcribed in response to environmental and antibiotic stresses by the alternative sigma factor σ B and additional DNA-binding proteins (Donegan and Cheung, 2009 ). Another possibility is that, similar to some type I TA systems, ezeT transcription is regulated by the SOS-response (Vogel et al., 2004; Kawano et al., 2007) .
Recent reports have shown that E. coli laboratory strains produce a plethora of different type II TA systems . To our surprise, except for the E. coli W strain, none of these laboratory strains encode for an EzeT TA system. Nevertheless, our bioinformatic studies showed that the EzeT encoding islet is found in almost every genome of commensal and pathogenic strains of the phylogroup B1 such as, for example, the Shiga-toxin-producing E. coli strains O104:H4 and O103:H2. Notably, phylogroup B1 isolates are predominantly found in locations with ambient temperature, e.g. soil (Walk et al., 2007) , on plants (Meric et al., 2013) , in the gastrointestinal tract of ectotherms (Gordon and Cowling, 2003) , and show prolonged survival times outside the host (Berthe et al., 2013) . Strikingly, we found that EzeT toxicity is temperature-dependent and activity is highest at low temperature as described earlier for the GraTA system from the soil bacterium Pseudomonas putida (Tamman et al., 2014) . In fact, EzeT is inactive in E. coli grown at 37°C, suggesting that EzeT is a thermosensor that is activated only when E. coli is exposed to lower temperature, presumably after excretion from the host.
It is tempting to speculate that autoinhibited TA systems are much more prevalent in bacterial genomes than anticipated. Most of the published, genome-wide bioinformatic studies that aim at identification of type II TA systems have restricted their search on bicistronic operons that encode small proteins (Leplae et al., 2011 , Makarova et al., 2009 , Sberro et al., 2013 . Unfortunately, loci such as ezeT have been overlooked in these approaches. However, more flexible bioinformatic searches that included size, genomic context and domain conservation as scoring criteria identified a plethora of putative solitary toxin genes or genes that are larger than their homologues (Sevin and Barloy-Hubler, 2007) . Although further studies are needed to elucidate the functional mechanism of EzeT, we show that EzeT is a new type of TA system in which a cis-acting antitoxin is tethered to the toxin, revealing that there is tremendous need to reinforce investigation of single or unusually long toxin homologues.
Experimental procedures
Bioinformatics
The NCBI non-redundant nucleotide or protein collections were searched for homologous sequences using BLAST (Altschul et al., 1990; 1997) . Alignments and sequence identity calculations were performed in ClustalO (Sievers et al., 2011; Sievers and Higgins, 2014) and depicted with the AMAS server (Livingstone and Barton, 1993) and ALSCRIPT (Barton, 1993) . Protein secondary structure elements were predicted using PSIPRED v3.3 (Jones, 1999) .
Bacterial strains and growth conditions
Escherichia coli DH5α (Life Technologies, Darmstadt, Germany) was used as host strain during all cloning experiments and promoter studies and E. coli BL21-CodonPlus(DE3)-RIL (Stratagene, La Jolla, USA) for protein overexpression. E. coli W (DSM 1116 from the DSMZ, Braunschweig, Germany), which harbors the genomic islet containing the ezeT locus (Archer et al., 2011) was used for genomic integration and endogenous protein purification. Cells were transformed either by heat-shock or electroporation following standard procedures and plated on lysogeny broth (LB) agar plates. Cell cultures were grown in LB medium unless stated otherwise. The medium was supplemented with the appropriate antibiotics at the following concentrations: 100 μg ml 
Construct preparation
A detailed description of all cloning procedures for expression constructs, reporter plasmids and integration constructs can be found in the Supplementary Materials and Methods. Genomic integration to obtain E. coli W(EzeT-HA) was performed according to the Red/ET recombination protocol from Gene Bridges, Heidelberg, Germany (see Supplementary Materials and Methods).
Protein expression and purification
Escherichia coli BL21-CodonPlus(DE3)-RIL cells were transformed with a pET28b(EzeT) or pET28b(EzeT_K121A), respectively. The cells were grown to late-log phase (OD600 ∼ 1) at 37°C and the temperature was reduced to 16°C. Protein expression was induced by addition of 1 mM IPTG for 18 h. Cells were harvested by centrifugation, resuspended in buffer A (50 mM of Tris-HCl pH 8.0, 150 mM of NaCl, 50 mM of (NH4)2SO4, 5 mM of 2-mercaptoethanol) and lysed by sonication. The cell debris was cleared by centrifugation and the supernatant was loaded on 2 ml nickel affinity resin (Qiagen, Venlo, Netherlands) equilibrated with buffer A. After washing with 20 ml buffer A, bound proteins were eluted with 20 ml buffer B [50 mM of Tris-HCl pH 8.0, 10 mM of (NH4)2SO4, 5% (w/v) glycerol, 250 mM of imidazole, 2 mM of 1,4-dithioerythritol (DTE) ] and instantly diluted with 25 ml of buffer C [50 mM of Tris-HCl pH 8.0, 10 mM of (NH4)2SO4 5% (w/v) glycerol, 0.5 mM ethylenediaminetetraacetic acid (EDTA), 2 mM DTE]. Subsequent to overnight dialysis against 1 l buffer D [50 mM of Tris-HCl pH 9.0, 2.5 mM of (NH4)2SO4, 5% (w/v) glycerol, 0.5 mM of EDTA, 2 mM of DTE] the protein solution was loaded onto a MonoQ 10/100 GL column (GE Healthcare, Little Chaltfont, UK) equilibrated with buffer D. Bound proteins were eluted in a linear gradient of 7.5 column volumes to buffer E [50 mM of Tris-HCl pH 9.0, 10 mM of (NH4)2SO4, 5% (w/v) glycerol, 0.5 mM of EDTA, 2 mM of DTE, 1 M of KCl]. The concentrated protein was applied to a Superdex75 10/300 GL column (GE Healthcare) equilibrated with buffer F [50 mM of HEPES-NaOH pH 7.5, 250 mM of KCl, 5% (w/v) glycerol, 2 mM of DTE]. EzeT and EzeT_K121A were expressed and purified following the same protocol. All purification steps were monitored by Coomassie-stained SDS-PAGE and the final protein was judged to be more than 99% pure.
Immunoprecipitation
Prior to immunoprecipitation 5 μg antibody [rat anti-HA highaffinity antibody (Roche, Basel, Switzerland, 3F10) ] were chemically cross-linked to protein G-Dynabeads (Life Technologies) using 5 mM bis(sulfosuccinimidyl)suberate at ambient temperature. The reaction was quenched after 1 h with 50 mM of Tris-HCl pH 7.5 and the beads were washed thoroughly with PBS-T buffer [phosphate buffered saline supplemented with 0.02 (v/v) polysorbate 20].
Escherichia coli W (control) and E. coli W(EzeT-HA) were grown at 37°C to OD600 = 1, 1 l of culture was harvested by centrifugation and incubated in 10 ml buffer (100 mM of TrisHCl pH 8.0, 150 mM of NaCl, 1 mM of DTE, 2 mM of EDTA) in the presence of 10 mg ml −1 lysozyme at 4°C for 30 min. After addition of 0.2 (v/v) polysorbate 20, the cells were lysed in an M-110S microfluidizer (Microfluidics, Westwood, USA) and the cell debris was cleared by centrifugation. The cross-linked antibody was added to the supernatant and incubated at 4°C under constant rotation for 2 h. Beads were retrieved using a magnetic field and washed thoroughly with PBS-T. Bound EzeT-HA was eluted from the cross-linked beads by protein denaturation with 8 M urea.
The eluted fractions were separated on SDS-15% (w/v) polyacrylamide gels and proteins were monitored by Western blotting using an anti-HA antibody (Abcam, Cambridge, UK ab9110, dilution 1:4000) as primary antibody and a horseradish peroxidase-conjugated anti-rabbit IgG antibody (Delta Biolabs, Gilroy, USA, dilution 1:5000) as secondary antibody. Chemiluminescence was detected using ECL Western blotting detection reagents (Amersham, Amersham, UK) following the manufacturer's protocol.
Circular dichroism spectroscopy
Circular dichroism was used to determine the melting point. Temperature unfolding was measured by determining the light polarization at 222 nm in a J-810 spectropolarimeter (Jasco, Gross-Umstadt, Germany). 200 μl of 10 μM of EzeTCHis in a buffer containing 50 mM of HEPES-NaOH pH 7.5, 250 mM of KCl and 1 mM of DTE was heated from 10°C to 70°C with a heat rate of ΔT/Δt = 1°C min −1 . The melting point was determined in Prism (GraphPad, La Jolla, USA) assuming a two-state unfolding process (Consalvi et al., 2000) .
Reporter assay
Escherichia coli DH5α cells were transformed with plasmids expressing sfGFP [pREP(sfGFP) ] under control of various versions of the endogenous promoter region of the ezeT operon from E. coli W. A single colony was used to inoculate 5 ml of growth medium and grown at 37°C overnight. Subsequently, cell cultures were diluted to an OD600 of 0.1 and 200 μl aliquots of each culture were further incubated in 96-well plates (Corning, Inc., Corning, USA, 3651) under constant shaking at 37°C until stationary phase was reached. GFP fluorescence (excitation: 485 nm, emission: 510 nm) was monitored using a Varioscan Flash Multimode Reader (Thermo Scientific, Waltham, USA). Untransformed E. coli DH5α were used for background correction. To test for autorepression by EzeT, the protein was encoded from an additional pBAD(EzeT) plasmid. Expression was induced by addition of 0.2% (w/v) L-(+)-arabinose. For comparison, DH5α cells transformed with pREP(sfGFP) only were also exposed to arabinose.
UNAG phosphorylation assay
UDP-N-acetylglucosamine phosphorylation by EzeT was investigated in vitro following a slightly modified version of a previously described protocol . Briefly, 3 μM purified EzeT protein was incubated with 1 mM of ATP and 0.25 mM of UNAG at 25°C in a buffer containing 25 mM of HEPES-NaOH pH 7.5, 100 mM of NaCl, 5 mM of MgCl2. Individual reaction mixtures were diluted 1:2 with deionized H2O after 3 h and 24 h of incubation and applied to a MonoQ 5/50 GL (GE Healthcare) equilibrated with deionized H 2O. The reaction was separated in a linear gradient of 33 column volumes to 1 M (NH4) acetate pH 8.0.
Low-molecular-weight-metabolite extraction
Escherichia coli BL21-CodonPlus(DE3)-RIL cells were transformed with plasmids expressing either full-length, truncated or inactive and truncated EzeT and were grown to an OD600 = 0.2 at 37°C. Subsequently, cell cultures were cooled to 16°C and growth resumed until the OD600 reached 0.6. Protein expression was induced upon addition of 1 mM of IPTG. After 2 h of incubation, cells were harvested and lowmolecular-weight-metabolite extraction and analysis was performed as described previously .
Toxicity assay
Cultures of E. coli BL21-CodonPlus(DE3)-RIL transformed with plasmids expressing full-length, truncated or mutated EzeT were grown to OD600 = 0.1 at various temperatures and protein expression was induced with 1 mM of IPTG. Cell proliferation was monitored regularly by measuring the OD600 and by determination of CFUs. All experiments were performed in triplicates. Samples for the determination of protein expression levels were taken after 3 h of induction and separated on SDS-15% (w/v) polyacrylamide gels. His6-tagged proteins were detected by Western blotting using a Penta·His HRP conjugate (Qiagen, final dilution 1:2000). Chemiluminescence was detected using ECL Western blotting detection reagents (Amersham) following the manufacturer's protocol. In addition, phase contrast and fluorescence images were taken using an Axiovert 135 microscope (Zeiss, Oberkochen, Germany) equipped with a 100 × oil immersion objective lens (Plan-Neofluar, N.A. 1.3, Zeiss) and captured with a ProgRes C3 CCD camera (Jenoptic, Jena, Germany). Live/dead staining was performed using the LIVE/DEAD BacLight bacterial viability kit (Molecular Probes, Eugene, USA). Twenty microliters of cell suspensions, either directly from the expression culture or after mild concentration by centrifugation at 400 × g for 1 min, were mixed with 0.5 μl of a solution containing 1.67 mM of SYTO 9 and 1.67 mM pf propidium iodide. SYTO 9 (live) fluorescence was visualized with a 450-490 nm excitation filter and a 520 nm long pass emission filter, while propidium iodide (dead) fluorescence was visualized using a 545 nm band pass excitation filter and a 590 nm long pass emission filter.
For experiments studying the inhibition by the Nterminal domain in trans, E. coli BL21-CodonPlus(DE3)-RIL were co-transformed with pET28b[EzeT(1-82)] and pBAD(EzeTΔN83). Cell cultures were grown in glucose-free medium (0.2% (w/v) caseine hydrolysate, 0.2% (v/v) glycerol, 1 mM MgSO4, 6 g Na2HPO4, 3 g KH2PO4, 0.5 g NaCl, 1 g NH4Cl) at 37°C to OD600 = 0.1-0.2, cooled to 16°C and expression of the C-terminal domain from pBAD(EzeTΔN83) was induced with 0.2% (w/v) L-(+)-arabinose after 1 h. Expression of the N-terminal domain from pET28b[EzeT(1-82)] was induced by addition of 1 mM IPTG at various time points.
PI influx
Membrane permeabilization was investigated following a slightly modified version of a previously described protocol . Cultures of E. coli BL21-CodonPlus(DE3)-RIL transformed with plasmids expressing full-length, truncated or mutated EzeT were grown at 20°C. When an OD600 ∼ 0.15 was reached, these cultures were mixed with an equal volume of LB medium supplemented with 0.1 mg ml −1 propidium iodide (Sigma-Aldrich, St. Louis, USA) and 2 mM IPTG. 200 μl of these mixtures were transferred into a 96-well plate (Corning 3651, Corning, Inc.) and OD600 and propidium iodide fluorescence (excitation: 520 nm, emission: 620 nm) were monitored using a Varioscan Flash Multimode Reader (Thermo Scientific).
